*By clicking the Submit button, I consent to being contacted by Altman-Nussbaum-Shunnarah Personal Injury Attorneys at the number I provided. I also consent to receiving advertisements and telemarketing messages by text message or pre-recorded call, either of which may be dialed by an autodialer. I acknowledge that my consent is not required for purchase, that standard message and data rates apply, and that clicking Submit constitutes my electronic signature for my consent to being contacted and my agreement to the Terms and Conditions.
The experienced attorneys at Altman-Nussbaum-Shunnarah have helped clients across the country recover over $1 billion.
Belviq weight loss drugs have been linked to cancer. You need an attorney that has the knowledge and experience in such cases.
Belviq and its extended formula Belviq XR is prescribed for weight-loss in adults with weight-related medical conditions. The drugs are manufactured by Japanese company Eisai Inc. Belviq is known as a selective serotonin 2C receptor agonist, which means it activates very specific parts of your brain that make you feel full. Less hunger leads to less eating, which leads to weight loss.
In February 2020, Belviq was offically recalled by the United States Food and Drug Administration (FDA), after a 5-year study showed convincing links to various forms of cancer. The FDA directed patients to stop taking Belviq and its extended formula variant Belviq XR immediately and dispose of leftover pills. They also issued directives to doctors to discontinue prescribing the treatment to their patients.
Certain forms of cancer were more pronounced in the FDA’s findings:
Unfortunately, these three cancers rank 1st, 2nd and 4th among the deadliest, with an annual death toll totaling more than 250,000 people. The most recent FDA study noted 7.7% of people that were administered Belviq developed some form of cancer.
The Belviq recall makes the manufacturer’s behavior even more egregious considering trials showed tumor growth in rats as far back as 2010, well before its approval in 2012. The manufacturer of Belviq, Eisai Inc., released a statement that they disagreed with the FDA’s findings, though they agreed to a self-recall of the drug as well.
Altman-Nussbaum-Shunnarah Trial Attorneys is known nationwide for providing outstanding legal advice and excellent representation. We have recovered over $1 billion in lawsuits involving 18 wheeler trucking litigation, wrongful death litigation, commercial vehicle litigation, motorcycle litigation, catastrophic litigation, and mass torts involving medical devices and bad drug litigation. Our prowess in the legal arena comes from our combined years of trial and complex litigation experience.
We founded our practice on the belief that the 7th amendment and the civil jury system is the best means to provide compensation to injured parties and deter wrongdoers from injuring others in the future.
*By clicking the Submit button, I consent to being contacted by Alexander Shunnarah Personal Injury Attorneys at the number I provided. I also consent to receiving advertisements and telemarketing messages by text message or pre-recorded call, either of which may be dialed by an autodialer. I acknowledge that my consent is not required for purchase, that standard message and data rates apply, and that clicking Submit constitutes my electronic signature for my consent to being contacted and my agreement to the Terms and Conditions.
